Genomics England – The Generation Study – CAH included

Mar 15, 2024

The Generation Study is being carried out by Genomics England in partnership with the NHS. It is exploring the possible use of genome sequencing in newborn babies to identify a wide range of rare genetic conditions alongside the routine newborn blood spot screening. The study will include 100,000 newborns and the first participants are expected to join the study in the next few weeks. 

As part of the study, Genomics England have created a list of rare conditions and associated genes that they will be looking for – and CAH is included. These conditions are chosen by following four key principles

An extract of the list showing the types of CAH which are included is below:

Condition Group Gene Condition name
Congenital adrenal hyperplasia CYP17A1 17-alpha-hydroxylase/17,20-lyase deficiency
Congenital adrenal hyperplasia CYP21A2 *This gene meets the principles to be included, however it is not currently being analysed due to further internal work being required Congenital adrenal hyperplasia due to 21-hydroxylase deficiency
Congenital adrenal hyperplasia CYP11B1 Adrenal hyperplasia, congenital, due to 11-beta-hydroxylase deficiency
Congenital adrenal hyperplasia HSD3B2 Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency

The list is being kept under constant review throughout the study and is subject to change as new evidence emerges. Genomics England is working with the NHS in England to ensure availability of treatments and to confirm that the genome sequencing technology used in the study can reliably identify changes in the genes causing these conditions.  

The results of the study will add to evidence that will inform future decisions on using whole genome sequencing to support newborn screening. This includes using it to accelerate diagnosis and access to treatments for rare conditions.

 

More information

Genomics England homepage – https://www.genomicsengland.co.uk/

The Generation Study – https://www.genomicsengland.co.uk/initiatives/newborns

 

 

Recent Blog Posts

2026 CAH Support Group Conference, 28th June, Sheffield

2026 CAH Support Group Conference, 28th June, Sheffield

SUNDAY 28th JUNE 2026 9.30 -16:00 The Old Rectory, Handsworth, Sheffield, S13 9BZ theoldrectoryhandsworth.co.uk Those living with CAH and their families and friends are invited to the biennial conference of CAH Support Group. Visit our online booking page here to find...

A selection of articles from around the world in 2025

A selection of articles from around the world in 2025

Here’s a selection of three articles from around the world in 2025 about CAH. They cover treatment methods and long term outcomes for people with CAH - making for interesting reading for anyone interested in or affected by CAH. These articles are not a recommendation...

COVID-19 Information & Guidance

COVID-19 Information & Guidance

As new guidance and information becomes available, we will do our best to link to it below - please check here for updates. If you contract COVID-19, remember to adhere to sick-day rules. Always seek guidance from your GP, endocrinologist or other appropriate medical...

The CAH Support Group is affiliated with Society for Endocrinology, an organisation that supports clinicians, scientists and nurses who work with hormones throughout their careers. They engage policy-makers, journalists, patients and the public with hormone science to encourage informed health decisions, and to demonstrate the value of endocrinology to the wider world and also maintains a public information website, You and Your Hormones.

All content on this website (livingwithcah.com) is copyright the CAH Support Group unless otherwise stated.

The CAH Support Group cannot be held responsible for the content provided by any external links unless stated.

Cookie Policy | Privacy Policy | Disclaimer | Forum & Social Media Rules | Contact Us